Advertisement
Dentistry
Subscribe to Dentistry
View Sample

FREE Email Newsletter

OrthoAccel Technologies, Inc. Announces New Scientific Advisor

February 23, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

HOUSTON, Feb. 23, 2011 /- OrthoAccel Technologies, Inc.  developers of the  AcceleDent System , a medical device to accelerate orthodontic treatment, announced this week that it has engaged Dr. Dawei Liu as a scientific advisor. Dr. Liu's guidance and expertise will help advance...

American Legion: St. Louis VA Acted Quickly, Correctly

February 22, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Feb. 22, 2011 /PRNewswire-USNewswire/ -- The Department of Veterans Affairs acted swiftly and correctly to temporarily suspend surgeries earlier this month at the John Cochran VA Medical Center in St. Louis after stains and water spots were noticed on some medical trays and...

Covidien Announces FDA 510(k) Clearance of New LigaSure(TM) Instrument

February 16, 2011 2:34 am | by Covidien | News | Comments

New "small jaw device" puts multi-functionality in the surgeon's hands BOULDER, Colo., Feb 16, 2011 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the...

Advertisement

More Patient Burns from Dental Handpieces

February 15, 2011 9:31 am | by USFoodandDrugAdmin | Videos | Comments

FDA is again alerting dental professionals about the possibility of serious patient burns from electric dental handpieces that overheat. Some patients have experienced third-degree burns that required reconstructive surgery. Although FDA issued a warning about this problem in 2007, the...

Commonly Prescribed Osteoporosis Drug Associated with Very Low Risk of Serious Jaw Disease

February 14, 2011 7:34 am | by Bio-Medicine.Org | News | Comments

PORTLAND, Ore., Feb. 14, 2011 /- A commonly prescribed osteoporosis drug is associated with a slightly elevated risk of developing the rare, but serious condition, osteonecrosis of the jaw; nonetheless the risk remains extremely low.  These findings are published online in the...

Parents, Physicians Unite and Declare: State of Emergency

February 10, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

BRADENTON, Fla., Feb. 10, 2011 /- 'We are in a State of Emergency at the hands of prescription drugs.'  That is the message that concerned Florida residents are desperate for people to hear. Floridians are dying at a rate of at least 7 per day due to prescription drug abuse and...

Aerotel to Present Mobile Health and Telemedicine Solutions at Mobile World Congress 2011

February 8, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

BARCELONA, Spain, Feb. 8, 2011 /- Aerotel Medical Systems , a leading global supplier of advanced remote monitoring solutions for telehealth and telecare, will showcase its mobile health (mHealth) and other telemedicine solutions at the Mobile World Congress (MWC) 2011 in Barcelona, Spain...

Symmetry Medical to Host Investor Breakfast on February 17, 2011

February 8, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

WARSAW, Ind., Feb. 8, 2011 /- Symmetry Medical Inc. (NYSE: SMA ), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today that the Company will host an Investor Breakfast on Thursday, February 17, 2011 at 7:30 a.m....

Advertisement

Henry Schein to Webcast Fourth Quarter 2010 Conference Call Tuesday, February 22, at 10:00 a.m. EST

February 8, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

MELVILLE, N.Y., Feb. 8, 2011 /- Henry Schein, Inc. (Nasdaq: HSIC ), the largest provider of health care products and services to office-based practitioners, announced today that it will release its fourth quarter 2010 financial results before the stock market opens on Tuesday, February...

FDA Orders Postmarket Surveillance of Certain TMJ Implants

February 7, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Feb. 7, 2011 /PRNewswire-USNewswire/ -- Today the U.S. Food and Drug Administration ordered three manufacturers of temporomandibular joint (TMJ) implants to conduct postmarket surveillance studies to determine the length of time before the implants are removed or...

Henry Schein to Present at the UBS 21st Annual Global Healthcare Services Conference

February 7, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

MELVILLE, N.Y., Feb. 7, 2011 /- Henry Schein, Inc., (Nasdaq: HSIC ), the largest provider of health care products and services to office-based practitioners, announced today that Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, and Steven Paladino, the Company's...

Young Innovations, Inc. Provides 4th Quarter Conference Call Details

January 27, 2011 1:34 pm | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Jan. 27, 2011 /- Young Innovations, Inc. (Nasdaq: YDNT ) today announced that it will broadcast its fourth quarter earnings results with a live and on-demand web cast conference call on Thursday, February 3, 2011 at 11:00 a.m. Central Time. A live audio broadcast of the call...

Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2011 Results

January 21, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

GLENWOOD, Ill., Jan. 21, 2011 /- Landauer, Inc. (NYSE: LDR ), will release financial results for the fiscal first quarter of 2011 pre-market on Tuesday, February 1, 2011. The company will host a conference call for investors on Tuesday, February 1, 2011, at 2:00 p.m. Eastern Time....

Advertisement

Reportlinker Adds Dental Implants and Biomaterials - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

January 20, 2011 3:39 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Jan. 20, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Dental Implants and Biomaterials - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016...

Nonin Medical, Inc. Launches New WristOx2â„¢, Model 3150 in U.S. and Canada

January 19, 2011 10:38 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Jan. 19, 2011 /- Nonin Medical, Inc., the inventor of fingertip pulse oximetry and an innovator of noninvasive physiological monitoring solutions, today announced the United States and Canadian launches of its WristOx2™, Model 3150 wrist-worn pulse oximeter. (Photo:...

Zimmer Holdings Announces Live Audio Webcast and Conference Call of Fourth Quarter and Year End 2010 Results

January 14, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

WARSAW, Ind., Jan. 14, 2011 /- Zimmer Holdings, Inc. (NYSE and SIX: ZMH) announced today its fourth quarter 2010 sales and earnings conference call will be broadcast live over the Internet on Thursday, January 27, 2011, at 8:00 a.m. Eastern Time.  A news release detailing the...

$1,700,000 Funding of NeoStem's Very Small Embryonic-Like Stem Cells Being Developed to Treat Osteoporosis Recommended by the Department of Defense Peer Reviewed Medical Resea...

January 13, 2011 4:37 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Jan. 13, 2011 /- NeoStem, Inc. (NYSE Amex: NBS ) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced that its FY2010 Technology/Therapeutic Development Award application number PR101055 has been...

Allegiance Health in Michigan Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service

January 13, 2011 4:37 am | by Baxter | News | Comments

CHICAGO, Ill. - January 13, 2011 - In honor of its broad-based efforts to improve the lives of the most vulnerable members of its community, Allegiance Health in Jackson, Mich., is the recipient of the 2010 Foster G. McGaw Prize for Excellence in Community Service, one of the most esteemed commun

Water Street Healthcare Partners Acquires OraPharma, Inc.

January 5, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

CHICAGO, Jan. 5, 2011 /- Water Street Healthcare Partners announced today that it has acquired OraPharma, Inc. from Johnson & Johnson.  Water Street, a strategic private equity firm focused exclusively on health care, plans to build OraPharma into a leading specialty...

Edge EHR Corp. Announces edgeDMS for iPad, Native Touch-Based Clinical Charting Software for the Paperless Dental Office.

December 22, 2010 2:34 am | by Bio-Medicine.Org | News | Comments

SEATTLE,  Dec. 22, 2010 /- Edge EHR Corp., EDGE, a provider of Dental  Practice Management solutions for the Mac OS®, is pleased to announce the release of edgeDMS™ for iPad® for Dentists and Dental offices looking to leverage the awesome power of...

Mesa Labs Acquires the Biological Indicators Business of Apex Laboratories, Inc.(2)

December 21, 2010 5:34 pm | by Bio-Medicine.Org | News | Comments

LAKEWOOD, Colo., Dec. 21, 2010 /- Mesa Laboratories, Inc. (Nasdaq: MLAB ), a Lakewood, Colorado based manufacturer of electronic instruments and disposables today announced the acquisition of the biological indicators business of Apex Laboratories, Inc., a North Carolina based company....

Zimmer Holdings to Present at 29th Annual J.P. Morgan Healthcare Conference

December 16, 2010 4:35 pm | by Bio-Medicine.Org | News | Comments

WARSAW, Ind., Dec. 16, 2010 /- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal care, announced that it will be participating in the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on January 10, 2011, at 12 p.m. Eastern Time. A...

Sage Products and 3M Infection Prevention Announce Agreement

December 15, 2010 5:32 am | by Bio-Medicine.Org | News | Comments

CARY, Ill. and ST. PAUL, Minn., Dec. 15, 2010 /- Sage Products, Inc. and the 3M Infection Prevention Division have entered into an agreement in which Sage Products will purchase pre-filled, single dose bottles of 3M™ Peridex™ Oral Rinse for its Q-Care® Rx systems,...

Reportlinker Adds European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering 2011

December 14, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 14, 2010 /- Reportlinker.com announces that a new market research report is available in its catalogue: European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering 2011...

Zoledronic Acid Did Not Improve Disease Free Survival in Early Breast Cancer

December 9, 2010 9:33 am | by AACR | News | Comments

SAN ANTONIO - Zoledronic acid did not improve disease free survival among women with stage II/III breast cancer according to results of the Adjuvant Treatment with Zoledronic Acid in Stage II/III Breast Cancer (AZURE) trial, which was presented at the 33rd Annual CTRC-AACR San Antonio...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading